Re: novice chart analyst
my gut says we see 15 some time before approval- the serious question will be whether to sell then or hope for that buyout north of 25 possibly as high as 50. Tough call as if approved the market is immense and the already approved pricing reimbursement levels suggest big profit for a Pharma for years to come and possible oncology in the wings. It would be a nice problem to have once again though most of us didn't sell the first time around so doubt many would this time either since 15 is barely a 600 million market cap.